Elevated levels of CEA in cases (all stages) compared with non-cancer controls were significant up to 2 years before diagnosis (P<0.05) and could also discriminate cancers from benign neoplasms (data not shown). This evidence concerns the gene CEACAM5 and benign neoplasm.